普米克令舒雾化吸入治疗慢性阻塞性肺病急性加重期的疗效观察被引量：3

Observation on Pulmicort Repules Inhalation of Foggy in the Treatment of Chronic Obstructive Pulmonary Disease at Acute Exacerbation Phase

下载PDF

导出

摘要目的观察普米克令舒雾化吸入治疗慢性阻塞性肺病(COPD)急性加重期的临床疗效。方法60例COPD急性加重期患者随机分为对照组和观察组。两组均给予抗感染、吸氧、抗炎、平喘、解痉、化痰及对症等治疗,观察组加用普米克令舒雾化吸入,比较两组治疗前和治疗后1d、3d及10d的临床症状评分,第一秒用力呼气容积(FEV1)占用力肺活量(FVC)百分比(FEV1/FVC)及动脉血气分析的变化。结果两组治疗后1d、3d及10d的临床症状、肺功能及动脉血气均明显改善(P<0.05),观察组与对照组比较临床症状评分、FEV1/FVC、PaO2和PaCO2改善更明显(P<0.05)。结论普米克令舒雾化吸入治疗慢性阻塞性肺疾病急性加重期的疗效显著。 Objective To observe the clinical effect of pulmicort repulse inhalation on acute exacerbation of chronic obstructive pulmonary disease.Methods 60 patients with acute exacerbations of COPD were randomly divided into two groups(the observation group and the control group).The basic regiments for the two groups were oxygen,antibiotics,antiasthmatic,spasmolysis,phlegm,and the observation group was given pulmicort repulse by nebulizer.All patients underwent clinical symptom score,pulmonary function test and art...

作者丁宇栋

机构地区苏州市立医院本部急诊内科

出处《中国血液流变学杂志》 CAS 2008年第4期546-548,共3页 Chinese Journal of Hemorheology

关键词慢性阻塞性肺疾病普米克令舒 chronic obstructive pulmonary disease pulmicort repules

分类号 R563.9 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献8

1[2]Casaburi R,Briggs DD Jr,Donohue JF,et al.The spirometric efficacy of once-daily dosing with tiotropium in stable COPD:a 13-week multicenter trial.The US Tiotropium Study Group[J].Chest,2000,118(5):1294～1302.
2[3]Niewoehner DE.The role of systemic corticosteroids in acute exacerbation ofchronic obstructive pulmonary disease[J].Am J Respir Med,2002,1(4):243～248.
3[4]Walsh LJ,Lewis SA,Wong CA,et al.The impact of oral corticosteroid use on bonemineral density and vertebral fracture[J].Am J Respir Crit Care Med,2002,166(5):691～695.
4[5]Szefler SJ,Lyzell E,Fitzpatrick S,et al.Safety profile of budesonide inhalation suspension in the pediatric population:worldwide experience[J].Ann Allergy Asthma Immunol,2004,93(1):83～90.
5[6]Maltais F,Ostinelli J,Bourbeau J,et al.Comparison of nebulized budesonide and oral prednisolone wish placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease:a randomized controlled trial[J].Am J Repir Crit Care Med,2002,165(5):698～703.
6[7]Mirici A,et al.Comparison of the efficacy of nebulised budesonide with parenteral corticosteroids in the treatment of AECOPD[J].Clin Drug Invest,2003,23:55～62.
7[8]Renkema TE,Schouten JP,Koeter GH,et al.Effects of longterm treatment with corticosteroids in COPD[J].Chest,1996,109(5):115～1162.
8[9]Johnell O,Panwels R,Lfdahl CG,et al.Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide.Turbuhaler[J].Eur Rsepir J,2002,19(6):1058～1063.